March Lecture Topic
Targeting Unconventional T Cells in Cancer
In this seminar, Li Zhou, Ph.D., will provide an overview of two distinct subsets of unconventional T lymphocytes: invariant natural killer T (iNKT) cells and mucosal-associated invariant T (MAIT) cells. She will highlight recent findings on iNKT cell activation and the gut microbiota–liver MAIT cell axis in the development and progression of pancreatic cancer liver metastasis (PCLM). Her research suggests that targeting iNKT and MAIT cells may represent a promising immunotherapeutic strategy for PCLM.
Virtual Information
Teams Meeting
Meeting ID: 247 010 599 074 6
Passcode: Ew3Us3c9
Location
MSU Interdisciplinary Science Technology Building (ISTB)
Room 1404
766 Service Rd
East Lansing, MI
About the Guest Speaker
Li Zhou, Ph.D., is a senior scientist in the Center for Cutaneous Biology & Immunology, Department of Dermatology, and the Immunology Program at the Henry Ford Cancer Institute, Henry Ford Health. She is also a professor in the Department of Medicine at Michigan State University.
Her laboratory focuses on immune regulatory mechanisms in cancer, autoimmune diseases, and cancer immunotherapy. Zhou has published over 100 peer-reviewed articles and currently holds two NIH grants, including an NCI R01 award.